Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity from Department Of Defense was posted on September 17, 2019. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Laboratory reagents for molecular biology

Closed
VEID190567Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424210
New
SLED
Purchase of Antibiotics
Solicitation # 2026-Informal-0210
The City of Pasadena Public Health Department is soliciting quotes for a one-time purchase of antibiotics to stockpile for post-exposure response to Category A agents, including anthrax, plague, and tularemia. The procurement consists of 30,000 tablets of Ciprofloxacin (500mg/dose) and 200,000 tablets of Doxycycline Hyclate (100mg/dose). All materials must be delivered to the Public Health Department at 1845 N Fair Oaks Ave, Pasadena, CA, within four business days of being ordered, with the entire purchase completed by the end of the fiscal year on June 30, 2027. Vendors must strictly adhere to FDA and CDC regulatory standards for manufacturing, distribution, and recordkeeping. Key requirements include the use of cold-chain storage and temperature-monitoring devices during transit to prevent physical damage or temperature fluctuations. All products must be accurately labeled with lot numbers, expiration dates, and manufacturing details to ensure full lot-level traceability. Bidders are required to submit pricing through the City's eProcurement Portal, and quoted unit prices must include all delivery costs, sales tax, and freight fees. Compliance requirements are extensive, including adherence to the Davis-Bacon Act, Buy American provisions, and Equal Employment Opportunity practices. Bidders must provide a Unique Entity Identifier (UEI), a completed IRS Form W-9, and certifications regarding lobbying and federal financial assistance. Evaluation is based on competitive pricing and responsiveness, with a requirement for vendors to demonstrate relevant experience and maintain necessary insurance and licenses.
Public Health Department

POSTED

1 day ago

DEADLINE

in 7 days
NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATION
Solicitation # SPE2DP-27-T-0183
This solicitation, identified as SPE2DP-27-T-0183, is a Request for Quotations for the procurement of sunscreen preparation under NSN 6505-01-657-9247. The required product is an over-the-counter topical sunscreen with an SPF of 50, containing 4.5% titanium dioxide and 4% zinc oxide. It must be sweat and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, and biodegradable. The unit of issue is a package of 24 three-ounce tubes. The product has a total shelf life of 24 months, with a minimum of 21 months remaining upon receipt by the government. Storage requirements are specified between 15 and 30 degrees Celsius in a cool, dry place. The contract specifies a delivery timeframe of five days with an original required delivery date of July 21, 2026. Delivery is FOB Destination, with shipments directed to locations including Fort Bragg, North Carolina, and North Stonington, Connecticut. Packaging must adhere to ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials, with palletization following RP001. Marking must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and payment requests. The procurement is subject to various federal regulations, including the Buy American Act and DFARS cybersecurity reporting standards. Quotes must be submitted via the DLA Internet Bid Board System. The solicitation is managed by the Medical Supply Chain Pharma FSA under the Department of Defense, with a primary point of contact at DLA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 5 days
NAICS: 424210
New
DIBBS
REHYDRATION SALTS FOR
Solicitation # SPE2DP-27-T-0184
Solicitation SPE2DP-27-T-0184 is a request for quotations from the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of lemon-flavored electrolyte oral rehydration powder, identified by NSN 6505-01-646-2692. The product is an over-the-counter oral solution powder provided in packages containing 100 packets, with each 21 gram packet formulated to provide 665 mg of sodium, 390 mg of potassium, 80 mg of citrate, 83 mg of magnesium, and 3 mg of zinc when mixed with 16.9 fluid ounces of water. The items have a non-extendable shelf life of 24 months and are regulated by the FDA. The contract includes three CLINs with total quantities of 13 packages to be delivered to various destinations, including the USNS Richard E Byrd, USNS John Lenthall, and NAVSHIPYD & IMF Det Guam. Delivery is required within five days after the order, with required delivery dates set for October 27 and 28, 2026. Shipping is FOB Destination, and inspection and acceptance will occur at the destination. Packaging must comply with DLA Master List requirements, MIL-STD-129 for marking, and ASTM D3951 for non-hazardous commercial packaging, while palletization must follow RP001 standards. Administrative requirements include electronic invoicing via Wide Area WorkFlow and compliance with the Buy American Act, the Berry Amendment, and DFARS cybersecurity reporting standards. The solicitation is a candidate for automated award and incorporates the DLA Master Solicitation for Automated Simplified Acquisitions Revision 105. Evaluation may include a HUBZone price preference, and offers utilizing additive manufacturing are ineligible for award. The primary point of contact for this procurement is James McCullough.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 5 days

General Info

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

Venezuela Avenue Block 36 Bellavista-Callao, Lima, DC, PER

Set-Aside

NONE

Documents

1

VEID190567_J%26A_17Sep19.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

1 update
PhaseClosed
Posted

Presolicitation

Notice updated

Response deadline changed from Sep 16, 2019 to Sep 26, 2019. The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Naval Medical Research Unit South
Contacts1 person available
OfficeWASHINGTON, DC, 20521-3230, USA
Office AddressWASHINGTON, DC, 20521-3230, USA
Contacts
Genaro M VasquezCONTRACT SPECIALIST

Full Description

Show more
The Virology & Emerging Infections Department of the U.S. Naval Medical and Research Unit No. 6 (NAMRU-6) is seeking to purchase laboratory reagents to be used for molecular diagnosis of influenza virus, adenovirus, Metapneumovirus, Enterovirus, Rhinovirus, Respiratory Syncytial Virus, Mayaro, dengue, Chikungunya, and Zika virus. Specifically, requirement involves reagents for reverse transcription, and real-time platforms used for detection of human influenza viruses (Influenza A-matrix gene and B) and its subtypes (H3, H1pdm/SwH1N1, H1 seasonal and H5) (SOP N6-VIR-MB RV 014); detecting genetic material of Adenovirus in nasal and pharyngeal swab specimens (SOP N6-VIR-MB RV 007); detecting the genetic material of Metapneumovirus (MPV), Enterovirus, Rhinovirus and Respiratory Syncytial Virus in nasal and pharyngeal swabs specimens using a reverse transcription (N6-VIR-MB RV 006); and, amplification of the whole genome of the influenza A virus based on the amplification of full-length gene segments for SNP genotyping, gene expression analysis and genotype (N6-VIR-MB RV 001) and pathogen discovery in respiratory and serum samples collected in our surveillance protocols. All these NAMRU-6 assays have been developed independently for each SOP and involve much time and effort by laboratory technicians, and supervisors for final approval. Reagents used must remain the same as the ones indicated in the SOPs, otherwise the design and validation of these processes would have to be initiated from zero, which would delay all processing and the timely diagnosis of public health relevant pathogens.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS